Viewing Study NCT00987168


Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2026-02-20 @ 6:25 PM
Study NCT ID: NCT00987168
Status: COMPLETED
Last Update Posted: 2013-12-19
First Post: 2009-09-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sandostatine® LP and Hyperinsulinism
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Congenital Hyperinsulinism View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Congenital Hyperinsulinism View
None Hypoglycemia, View
None Sandostatine subcutaneous in 3 daily injections View
None Intramuscular injection of Sandostatine® LP per month View